Most retrieval-augmented models work by breaking down documents into small chunks and retrieving only the most relevant ones. However, this approach has some limitations: Loss of Context: Retrieving ...
Abstract: Merge trees are a valuable tool in the scientific visualization of scalar fields; however, current methods for merge tree comparisons are computationally expensive, primarily due to the ...
ABSTRACT: The aim of this work was to study the competition between Helicobacter pylori isolates susceptible to clarithromycin and their resistant mutants, in terms of growth, by co-culture over an ...
Recursion Pharmaceuticals, Inc. remains a Sell as pipeline progress, notably REC-4881 in FAP, fails to surpass cheap alternatives like Celebrex. REC-4881's Phase 1/2 data show a median polyp reduction ...
Dec 8 (Reuters) - Recursion Pharma (RXRX.O), opens new tab, which uses artificial intelligence to discover new drug candidates, said on Monday its experimental oral drug helped reduce abnormal growths ...
Shares of Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) are trading higher Monday after the pharmaceutical company reported positive data from an ongoing trial. What To Know: Recursion ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback